UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On May 12, 2021, Neogen Corporation issued a press release announcing that the Board of Directors has approved a 2-for-1 stock split. A copy of the press release is attached as Exhibit 99.1 to this report.
This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 | Neogen Corporation Press Release dated May 12, 2021 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEOGEN CORPORATION | ||||||
(Registrant) | ||||||
Date: May 12, 2021 | /s/ Steven J. Quinlan | |||||
Steven J. Quinlan | ||||||
Vice President & CFO |
Exhibit 99.1
FOR IMMEDIATE RELEASE
CONTACT: | Steven J. Quinlan, Vice President and CFO | |
(517) 372-9200 |
NEOGEN Announces 2-for-1 Stock Split
LANSING, Mich., May 12, 2021 NEOGEN Corporation (NASDAQ: NEOG) announced today that its Board of Directors has approved a two-for-one stock split. Each stockholder of record at the close of business on May 26, 2021, will receive one additional share of common stock for each share held, with new shares expected to be distributed on June 4, 2021.
As of today, NEOGEN has approximately 53,700,000 shares of common stock outstanding. After the split, the company will have approximately 107,400,000 shares of common stock outstanding. The split is the sixth in the companys 39-year history, the most recent being a four-for-three stock split in December 2017.
We are pleased that the Board of Directors has approved this split, demonstrating their continued confidence in NEOGENs long-term growth, says John Adent, NEOGENs President and Chief Executive Officer. With this split, we will be able to increase the availability of NEOGEN stock and enhance liquidity within the marketplace, allowing both current and new investors to share in NEOGENs success.
Shareholders contemplating a transaction of NEOGEN stock between the record date and payment date should consult a broker regarding their entitlement to the split shares.
NEOGEN Corporation develops and markets products dedicated to food and animal safety. The companys Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. NEOGENs Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants.
###
Document and Entity Information |
May 12, 2021 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | NEOGEN CORP |
Entity Incorporation State Country Code | MI |
Amendment Flag | false |
Entity Central Index Key | 0000711377 |
Document Type | 8-K |
Document Period End Date | May 12, 2021 |
Entity File Number | 0-17988 |
Entity Tax Identification Number | 38-2367843 |
Entity Address, Address Line One | 620 Lesher Place |
Entity Address, City or Town | Lansing |
Entity Address, State or Province | MI |
Entity Address, Postal Zip Code | 48912 |
City Area Code | 517 |
Local Phone Number | 372-9200 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Y^R<&?4\"FHW5-^2^-OZ)IJGXU\-6.#!7_W)I[VM
M1^I27[&=&%2%(27UZX''1K^R\3)+EBIL2=H4$Y?ILQ>$3;(NDV!=F()WA->*
M,K '8QS!5$]8N,XH/01W4TO_4EDC*+OE8"KMF1\I)J5+I2H/2G!O07,!67
MY_;\O&(NS,W
#DY,2YH=&U02P4& 4 !0!8 0 %B,
end